Biomarkers and Precision Medicine Community (BPMC)

Clinical Biomarker Assay Validation: The Power of Western Blotting……Thinking Outside the Box!

• Introduce the AAPS initiative on guidelines to develop biomarker assays for the Western Blotting (WB) platform
• Review scope of the initiative and advantages of the WB Platform
• Discuss recommendations for the development/validation of biomarker assays on the WB platform
• Solicit feedback from the community and address open questions

Discussion Leaders:

• Arvind Kinhikar (Novartis)
• Mohammed Hassanein (Pfizer)
• Jake Harman (PPD)
• Joel Mathews (Ionis Pharmaceuticals)

Organized by:  Joel Mathews (Ionis Pharmaceuticals), Arvind Kinhikar (Novartis)